Results 131 to 140 of about 68,214 (292)

A Multidisciplinary Perspective on COVID-19 Exit Strategies

, 2022
Dablander F, Blanken T, Tanis CC, Breed R, Coffeng LE, Crommelin D, Edeling W, Gautier P, de Graaf B, Gugole F, van Harreveld F, Jager D, Jensen L, Knoeff R, van der Linde M, Sanderse B, De Ruijter A, de Vlas S, Santing C, Zwart B, Heesterbeek H, Borsboom D.   +21 more
europepmc   +1 more source

Partial abandonment as an exit strategy for troubled IT projects

, 2008
Gary Pan
openalex   +2 more sources

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

Molecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan, Irina Primac, Emre Etlioglu, Laurens Debruyne, Ann Janssen, Magy Sallam, Kevin Tabury, Roel Quintens, Wiebren Tjalma, Mohammed Abderrafi Benotmane   +9 more
wiley   +1 more source

Age, Death Risk, and the Design of an Exit Strategy: A Guide for Policymakers and for Citizens Who Want to Stay Alive [PDF]

, 2020
Andrew J. Oswald, Nattavudh Powdthavee
openalex   +1 more source

Brexit and the union: Territorial voice, exit and re-entry strategies in Scotland and Northern Ireland after EU exit [PDF]

, 2021
Nicola McEwen, Mary C. Murphy
openalex   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

The emergence of the Syrian conflict and exit strategies. (c2016) [PDF]

, 2016
Zouha Shaheen
openalex   +1 more source

The macroeconomics of COVID-19 exit strategy: the case of Japan [PDF]

, 2021
So Kubota
openalex   +1 more source

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source

Exit Strategies, Capital Flight and Speculative Attacks: Europe's Version of the Trilemma [PDF]

, 2017
Andreas Steiner, Sven Steinkamp, Frank Westermann   +2 more
openalex   +1 more source